Labcorp Holdings (LH) Current Deferred Revenue (2015 - 2026)

Labcorp Holdings has disclosed Current Deferred Revenue across 12 years of filings, most recently posting $405.2 million for Q1 2026.

• Current Deferred Revenue for Q1 2026 came in at $405.2 million, up 4.35% year-over-year; the trailing twelve-month figure through Mar 2026 was $405.2 million (up 4.35% YoY), and the FY2025 annual result was $439.1 million, up 11.96% from the prior year.
• Current Deferred Revenue came in at $405.2 million for Q1 2026 at Labcorp Holdings, down from $439.1 million in the prior quarter.
• In the past five years, Current Deferred Revenue ranged from a high of $586.7 million in Q1 2023 to a low of $310.6 million in Q4 2022.
• The 5-year median for Current Deferred Revenue is $398.0 million (2025), against an average of $426.1 million.
• Across the five-year window, Current Deferred Revenue plunged 44.39% in 2022 and soared 35.77% in 2023, its largest moves.
• Labcorp Holdings' Current Deferred Revenue stood at $310.6 million in 2022, then jumped by 35.77% to $421.7 million in 2023, then declined by 7.0% to $392.2 million in 2024, then advanced by 11.96% to $439.1 million in 2025, then declined by 7.72% to $405.2 million in 2026.
• The last three Current Deferred Revenue figures came in at $405.2 million (Q1 2026), $439.1 million (Q4 2025), and $391.6 million (Q3 2025), per Business Quant data.